Delivery Order SPE2DR25D2007-SPE2DR26FM43B
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $28,181.63 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on January 9, 2026, with an ultimate completion date of January 12, 2026. The contractor will perform from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger...
- The Defense Logistics Agency awarded a $6,125.90 delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Arimidex 1 mg tablets, with performance in Conshohocken, Pennsylvania and completion targeted for December 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $17,837.21 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) with a completion date of January 16, 2026. This is a firm fixed-price, non-set-aside contract with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $3,953.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg on December 29, 2025, with a completion date of December 30, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $33,960.54 delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Arimidex 1 mg tablets (30-count packaging). This firm fixed-price contract, with an ultimate completion date of January 15, 2026, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The award was made on a competitive, non-set-aside basis, reflecting...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $3,074.40 for 30 tablets of Arimidex 1 mg, with performance in Conshohocken, Pennsylvania. This competitive, non-set-aside contract reflects firm fixed pricing and is scheduled for completion on November 13, 2025. The award represents a single delivery order executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,648.43 on December 10, 2025, for the supply of Arimidex 1 mg tablets (30-count packages). This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by December 11, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a $19,490.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Arimidex 1 mg tablets (30-count units). This is a non-set-aside contract with a completion date of January 21, 2026, with performance fulfillment at the awardee's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $11.7K delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 20, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with a completion date of January 21, 2026, and performance at the awardee's facility in Conshohocken, Pennsylvania. The delivery order was executed under Amerisourcebergen's parent company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count) with a ceiling value of $8,162.69. This firm fixed price, non-set-aside contract was awarded on December 23, 2025, with an ultimate completion date of December 24, 2025. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM43BDelivery Order
The Defense Logistics Agency awarded a $56,492.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp (Corporate Office) on January 20, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30 units. This non-set-aside delivery order will be performed at the company's headquarters in Conshohocken, Pennsylvania, with completion expected by January 21, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s significantly larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and has demonstrated consistent capability in fulfilling federal medical procurement requirements through open competition. The company supplies a broad portfolio of pharmaceutical products to the Defense Logistics Agency and other federal healthcare systems, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Arimidex, a hormone therapy medication commonly used in oncology treatment, reflects the company's role as a critical vendor for military and veteran healthcare systems' pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.5k | 1/19/26 |